Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antihypertensive ergoline derivatives.

S Mantegani1, A Temperilli, G Traquandi

  • 1Chemical Research Department, Farmitalia Carlo Erba SpA, Milan, Italy.

Drug Design and Delivery
|May 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical Management of Tracheobronchomalacia in Children: Indications, Results and Techniques Based on a Large Case.

Journal of pediatric surgery·2025
Same author

Inventory of landslides triggered by an extreme rainfall event in Marche-Umbria, Italy, on 15 September 2022.

Scientific data·2023
Same author

Clinical and molecular delineation of a 16p13.2p13.13 microduplication.

European journal of medical genetics·2015
Same author

Molecular cytogenetic characterization of the first reported case of an inv dup (4p)(p15.1-pter) with a concomitant 4q35.1-qter deletion and normal parents.

Gene·2012
Same author

Late onset of pANCA renal and pulmonary vasculitis in a girl affected by undifferentiated connective tissue disease.

Lupus·2010
Same author

[Headache in a pediatric emergency department].

La Pediatria medica e chirurgica : Medical and surgical pediatrics·2009

Researchers developed novel ergoline compounds to find new antihypertensive drugs. Modifying the C8 side-chain improved blood pressure reduction in rats while maintaining safety.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Cardiovascular Research

Background:

  • Hypertension remains a significant global health challenge, necessitating the development of novel therapeutic agents.
  • Ergolines, a class of compounds derived from ergot alkaloids, have diverse pharmacological activities.
  • Existing antihypertensive treatments have limitations, driving the search for new drug classes.

Purpose of the Study:

  • To synthesize and evaluate novel ergoline derivatives as potential antihypertensive agents.
  • To assess the selectivity and safety profile of synthesized ergolines, including prolactin inhibitory effects, acute toxicity, and central nervous system (CNS) activity.
  • To identify key structural modifications that enhance antihypertensive efficacy and selectivity.

Main Methods:

Related Experiment Videos

  • Synthesis of a library of novel ergoline compounds.
  • Screening of ergolines for antihypertensive activity in spontaneous hypertensive rats (SHR).
  • Evaluation of prolactin inhibitory effects (nidation inhibition), acute toxicity (LD50), and CNS function (Irwin test) for safety and selectivity assessment.

Main Results:

  • Modification of the C8 side-chain of the ergoline skeleton significantly enhanced selective antihypertensive activity.
  • Introduction of substituents at other positions of the ergoline skeleton generally resulted in decreased selectivity or increased toxicity.
  • The C8 side-chain modification proved crucial for optimizing both efficacy and safety of ergoline-based antihypertensives.

Conclusions:

  • Novel ergoline derivatives, particularly those with modifications at the C8 side-chain, show promise as a new class of antihypertensive drugs.
  • Structural optimization of the C8 side-chain is critical for achieving selective antihypertensive effects and a favorable safety profile.
  • Further investigation into these ergoline derivatives could lead to the development of effective treatments for hypertension.